Skip to main content
. Author manuscript; available in PMC: 2020 Mar 1.
Published in final edited form as: Ann Allergy Asthma Immunol. 2018 Dec 19;122(3):296–301. doi: 10.1016/j.anai.2018.12.013

Table 1.

Patient demographics, season of histologic flare, and treatment at time of documented flare (N = 13)

Age at diagnosis (mean years ± SD) 32.3 ± 15.4
    Children < 18 years (N, %) 3 (23)
Age at first seasonal flare (mean years ± SD) 36.2 ± 14.5

Symptom length preceding diagnosis (mean years ± SD) 11.9 ± 11.3

Length of follow-up (mean years ± SD) 3.5 ± 1.6

% Male 85

% White 86

Any atopic disease diagnosis (n, %) 11 (85)
    Allergic rhinitis 11 (85)
    Food allergy(s) 8 (61)
    Eczema 3 (23)
    Asthma 2 (15)

Indication for repeat endoscopy when flare found (n, %)
    Routine surveillance or dilatation of stricture 9 (69)
    Flare of underlying atopic disease 1 (8)
    Worsening or persistent esophageal symptoms 3 (23)

Season of histologic flare per patient (n, %)
    Spring (March - May) 2 (14)
    Summer (June - August) 6 (43)
    Fall (September - November) 4 (29)
    Winter (December - February) 2 (14)

Patients with 1 or more histologic flares recorded 1 (8)

Treatment at time of flare
    Topical swallowed steroids 9 (69)
    6-mercaptopurine 1 (8)
    Food elimination diet 4 (31)
    Topical swallowed steroids + food elimination diet 2 (15)

Children: Less than 18 years old at appropriate time